Athersys Inc. extends relationship with Chicago-based investment fund

Athersys Inc. has struck a deal allowing the Cleveland-based developer of adult stem cell therapies to raise up to $25 million in equity capital from Aspire Capital Fund LLC , should it need the money.

http://www.crainscleveland.com/article/20131023/FREE/131029911?CSAuthResp=1%3A373516447986216%3A168216%3A4%3A24%3Aapproved%3A728EA028D3143F1C179B38DC59B1A6ED